HIV Vaccines

Tulsa Among Sites Testing AIDSvax Vaccine

Published in Vaccine Weekly, December 14th, 1998

Researchers in Tulsa, Oklahoma, are participating in a U.S. trial of a vaccine that may help prevent infection from HIV.

Tulsa is one of a handful of cities chosen to participate in final testing of the AIDSvax vaccine, developed by California-based VaxGen Inc.

Researchers are recruiting HIV negative gay men who are considered at high risk of contracting the disease. That includes those who are not in monogamous relationships. They also seek women who are in sexual relationships with HIV positive men or who have had more than one male sexual partner and have been diagnosed with sexually transmitted diseases within the past year.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1998-12-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry